Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Mar 01, 2024 3:39pm
55 Views
Post# 35910148

RE:RE:RE:RE:RE:RE:RE:Re: Up 39.39% in one week

RE:RE:RE:RE:RE:RE:RE:Re: Up 39.39% in one week
Tencents wrote: This is where the message gets mixed up

ceapro never talked about a biopharma company
its message from the ceo has always been
we are an expertise biotechnology company at extracting from plants and we plan to move to being a natural ingredient pharmaceutical/ nutritional company 


He talked about biopharma, and the AV pill could be that. There will be big $$$ if they are successuful and they could partner with biopharma is phase 1/2a is successful. We'll need a CEO who can handle this, not Gilles. Gille's proven that he cannot even license PGX CoQ10 although it has shown to have the best bioavailability compared to the gold standard. Amazing results were released in the fall of 2022 and nothing has become of it, "serious" negotiations seemed to have disappeared.
<< Previous
Bullboard Posts
Next >>